Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome

(2014) G. Iacobellis et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

(2010) Young Sun Kang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity

(2010) Alireza Esteghamati et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Adipokine Profile and Insulin Sensitivity in Formerly Obese Women Subjected to Bariatric Surgery or Diet-Induced Long-term Caloric Restriction

(2010) M. C. Mitterberger et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Visfatin is upregulated in type-2 diabetic rats and targets renal cells

(2010) Young Sun Kang et al.   KIDNEY INTERNATIONAL

The relationship between visfatin and metabolic syndrome in postmenopausal women

(2010) Jung-Ha Kim et al.   MATURITAS

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus

(2010) Hala O. El-Mesallamy et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adipokines and cardiometabolic function: How are they interlinked?

(2010) Aletta Elisabeth Schutte et al.   REGULATORY PEPTIDES

Skeletal muscle NAMPT is induced by exercise in humans

(2009) Sheila R. Costford et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

(2009) A. Garten et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

(2009) Sheng Wen Liu et al.   CLINICAL ENDOCRINOLOGY

Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women

(2009) Uğur Ünlütürk et al.   CLINICAL ENDOCRINOLOGY

Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome

(2009) Cheng-Chieh Lin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity

(2009) T. Romacho et al.   DIABETOLOGIA

Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes

(2009) N. P. E. Kadoglou et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells

(2009) James E P Brown et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke

(2009) Li-Fen Lu et al.   Journal of Stroke & Cerebrovascular Diseases

Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy

(2009) TAYFUN EYILETEN et al.   NEPHROLOGY

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells

(2008) Su-Ryun Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study

(2008) Ravi Retnakaran et al.   CLINICAL ENDOCRINOLOGY

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

(2008) Ming Zhong et al.   CLINICAL ENDOCRINOLOGY

Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans

(2008) M. Hallschmid et al.   DIABETES

Nuclear Factor- B Induction by Visfatin in Human Vascular Endothelial Cells: Its role in MMP-2/9 production and activation

(2008) R. Adya et al.   DIABETES CARE

Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction

(2008) M. Kovacikova et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

(2008) K M Choi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Plasma visfatin levels in normal weight women with polycystic ovary syndrome

(2008) Dimitrios Panidis et al.   European Journal of Internal Medicine

Intensive Glycemic Control Lowers Plasma Visfatin Levels in Patients with Type 2 Diabetes

(2008) J. Zhu et al.   HORMONE AND METABOLIC RESEARCH

The novel adipocytokine visfatin exerts direct cardioprotective effects

(2008) Shiang Y. Lim et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

(2008) M. I. Yilmaz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity

(2008) Alexis E. Malavazos et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Effect of Weight Loss on Proinflammatory State of Mononuclear Cells in Obese Women

(2008) Wayne H.-H. Sheu et al.   Obesity

Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women

(2007) Ji A Seo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE